Join
Live feed
·
PRReleasevia Quantisnow
Inhibrx Biosciences Inc. logo

Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program

ByQuantisnow·Wall Street's wire, on your screen.
INBX· Inhibrx Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INBX (Inhibrx Biosciences Inc.) and more on Quantisnow.